TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3910706

Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid (600 mg/day, 2 days before and 6 days after surgery)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 31657587

Group type: EXPERIMENTAL
Intervention: TT (teacher-training and coaching program without parental-awareness meetings)
Number of subjects: 0

Group type: COMPARATOR
Intervention: TTPA (teacher-training and coaching program with parental-awareness meetings)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TT and TTPA
Number of subjects: 0
Study: 29381796

Group type: EXPERIMENTAL
Intervention: ω-6 polyunsaturated fatty acids (PUFAs)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Saturated fatty acids (SFAs)
Number of subjects: 36
Study: 26395209

Group type: EXPERIMENTAL
Intervention: Video-supported group-based Otago exercise programme (OEP)
Number of subjects: 51
Study: 24571961

Group type: EXPERIMENTAL
Intervention: Cognitive Analytic Consultancy (CAC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 20
Study: 23020133

Group type: EXPERIMENTAL
Intervention: TRAP (thrombin receptor activating peptide)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: ADP (adenosine diphosphate)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: CRP (collagen-related peptide)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Area under the curve
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Half-maximal response
Number of subjects: 23
Study: 20124218

Group type: EXPERIMENTAL
Intervention: Oral 6-thioguanine (TG)
Number of subjects: 2027

Group type: COMPARATOR
Intervention: Oral 6-mercaptopurine (MP)
Number of subjects: 2027
Study: 18481439

Group type: EXPERIMENTAL
Intervention: Group A (shortwave diathermy, exercise, naproxen, activity modification)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Group B (shortwave diathermy, exercise, naproxen)
Number of subjects: 162
Study: 15700173

Group type: EXPERIMENTAL
Intervention: 50% gastrografin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 25% gastrografin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10% gastrografin
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0% gastrografin
Number of subjects: 24
Study: 12161768

Group type: EXPERIMENTAL
Intervention: Sildenafil (25-100 mg)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Phentolamine (40 mg)
Number of subjects: 242
Study: 12828169

Group type: EXPERIMENTAL
Intervention: Urapidil (25 mg intravenously)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg intravenously)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride)
Number of subjects: 45
Study: 8792442

Group type: EXPERIMENTAL
Intervention: 20mg low dose aspirin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40mg low dose aspirin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 80mg low dose aspirin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1639047

Group type: EXPERIMENTAL
Intervention: 500 g salmon daily for 40 days
Number of subjects: 9

Group type: COMPARATOR
Intervention: Basal diet (BD)
Number of subjects: 9
Study: 6735964

Group type: EXPERIMENTAL
Intervention: 300 mg daily tobramycin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 500 mg daily tobramycin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 200 mg daily tobramycin with 1000 mg neomycin
Number of subjects: 8
Study: 31766627

Group type: EXPERIMENTAL
Intervention: Appropriate for gestational age (AGA) birth weight
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Excessive body weight >4000 g
Number of subjects: 747

Group type: EXPERIMENTAL
Intervention: Greater body length
Number of subjects: 747
Study: 29137837

Group type: EXPERIMENTAL
Intervention: Game-based learning (GBL) intervention (Tapamole)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pamphlet intervention
Number of subjects: 60
Study: 27563681

Group type: EXPERIMENTAL
Intervention: Diabetes self-management (DSM)
Number of subjects: 400
Study: 24527599

Group type: EXPERIMENTAL
Intervention: Neurac training combined with conventional treatments for 2 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatments (cervical traction, manual therapy, electrical therapy) for 2 weeks
Number of subjects: 60
Study: 22569241

Group type: EXPERIMENTAL
Intervention: 130 mg dehydroepiandrosterone (DHEA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 20491724

Group type: EXPERIMENTAL
Intervention: Zonnic nicotine mouth spray (1 mg/spray)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Zonnic nicotine lozenge (2.5 mg)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nicorette gum (4 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 47
Study: 17493526

Group type: EXPERIMENTAL
Intervention: Belatacept group
Number of subjects: 28

Group type: COMPARATOR
Intervention: CsA group
Number of subjects: 28
Study: 15716708

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS
Number of subjects: 7665
Study: 12537316

Group type: EXPERIMENTAL
Intervention: New partially hydrolyzed formula
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional formula
Number of subjects: 16
Study: 10354839

Group type: EXPERIMENTAL
Intervention: Minimized low-weight polypropylene mesh (26.8 g/m2, pore size 5 mm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Common heavy-weight polypropylene mesh (90.2 g/m2, pore size 0.8 mm)
Number of subjects: 0
Study: 7493424

Group type: EXPERIMENTAL
Intervention: Topical ouabain
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral digoxin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical amiloride
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy individuals (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients
Number of subjects: 20
Study: 30915963

Group type: EXPERIMENTAL
Intervention: Touch-observation and task-based mirror therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study: 28859943

Group type: EXPERIMENTAL
Intervention: Screening for abdominal aortic aneurysm, peripheral arterial disease, and hypertension
Number of subjects: 50156

Group type: COMPARATOR
Intervention: No screening
Number of subjects: 50156
Study: 26547411

Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 250

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Daptomycin and Vancomycin
Number of subjects: 250
Study: 24053702

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy
Number of subjects: 0
Study: 21223512

Group type: EXPERIMENTAL
Intervention: Bezafibrate (200 mg twice daily)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (1 g twice daily)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 18318133

Group type: EXPERIMENTAL
Intervention: Wiferon (recombinant alpha2beta‐interferon)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arbidol
Number of subjects: 0
Study: 15983318

Group type: EXPERIMENTAL
Intervention: Statin therapy (0.4 mg cerivastatin daily, later replaced by 20 mg simvastatin)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 12802487

Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation (PAV)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Pressure Support Ventilation (PSV)
Number of subjects: 117
Study: 10937115

Group type: EXPERIMENTAL
Intervention: 35-mm camera (Nikon 6006)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Olympus D600L digital camera
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Kodak DCS 315 digital camera
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Olympus D320L digital camera
Number of subjects: 13
Study: 8649569

Group type: EXPERIMENTAL
Intervention: Topiramate 600 mg/day
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Topiramate 800 mg/day
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Topiramate 1,000 mg/day
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study: 1900685

Group type: COMPARATOR
Intervention: UFT
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: tegafur
Number of subjects: 210
Study: 6509109

Group type: EXPERIMENTAL
Intervention: Music (MU)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Autogenic training phrases and music (ATP & MU)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 30080428

Group type: EXPERIMENTAL
Intervention: Actual tDCS (20 min of anodal stimulation of the motor cortex at 2 mA)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 8
Study: 30409103

Group type: EXPERIMENTAL
Intervention: Gradual group (gradual changes in treadmill belts speed during adaptation)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Abrupt group (a single, large, abrupt change during adaptation)
Number of subjects: 26
Study: 26269397

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) 50 mg/week
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 208
Study: 25261913

Group type: EXPERIMENTAL
Intervention: Reversed total shoulder prosthesis (Delta X-tend)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Open reduction and internal fixation with angular stable plate (Philos) and thread cerclage
Number of subjects: 120
Study: 22223097

Group type: EXPERIMENTAL
Intervention: 25 g glucose drink
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: fat drink
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: protein drink
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo drink
Number of subjects: 18
Study: 21176197

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment of malaria in infants (IPTi)
Number of subjects: 0
Study: 19052352

Group type: EXPERIMENTAL
Intervention: IV Magnesium Sulphate (2g)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (IV normal saline)
Number of subjects: 60
Study: 15650664

Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone (BPTB) graft
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: 3-strand semitendinosus (ST) graft
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: 4-strand semitendinosus/gracilis (ST/G) graft
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: All groups (BPTB, ST, ST/G)
Number of subjects: 134
Study: 12460326

Group type: EXPERIMENTAL
Intervention: Prednisolone 10 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prednisolone 20 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 12198789

Group type: EXPERIMENTAL
Intervention: 1-D structure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4-D structure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ALCOVE model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rational model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Configural-cue model
Number of subjects: 0
Study: 7501203

Group type: EXPERIMENTAL
Intervention: Self-care styles
Number of subjects: 69
Study: 2029326

Group type: EXPERIMENTAL
Intervention: Immunization with husbands' lymphocytes
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Immunization with third party lymphocytes
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (immunized with their own lymphocytes)
Number of subjects: 99
Study: 7014814

Group type: EXPERIMENTAL
Intervention: Rapid rate ventilation (20 to 40/minute with a one-second inspiratory time)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Slow rate ventilation (60/minute with 0.5 second inspiratory time)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 30689825

Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 0

Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 0
Study: 29766257

Group type: EXPERIMENTAL
Intervention: 8-week walking-based exercise intervention consisting of 28 walking sessions, with 1 session per week supervised by a trained physiotherapist, spread over a maximum of 8 weeks (2-5 times/week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise advice on the benefits of exercise for people with RA
Number of subjects: 0
Study: 27021781

Group type: EXPERIMENTAL
Intervention: Tested with multiple-choice knowledge questions and provided feedback after each 5-min segment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Tested with multiple-choice knowledge questions but not provided feedback
Number of subjects: 120

Group type: COMPARATOR
Intervention: Watched the video without knowledge testing
Number of subjects: 120
Study: 24176997

Group type: EXPERIMENTAL
Intervention: QVA149 110/50 μg
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247

Group type: COMPARATOR
Intervention: Tiotropium 18 μg
Number of subjects: 247
Study: 22490579

Group type: EXPERIMENTAL
Intervention: rhNRG‐1 (10 μg·kg‐1·d‐1, I.V.) for 10 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Vehicle treatment
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham-operated animals (no treatment)
Number of subjects: 29
Study: 20649629

Group type: COMPARATOR
Intervention: Insulin glargine (evening regimen)
Number of subjects: 3181

Group type: COMPARATOR
Intervention: Insulin glargine (morning regimen)
Number of subjects: 3181
Study: 18616492

Group type: EXPERIMENTAL
Intervention: 3 mg of melatonin 60 min before the procedure (group I)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5 mg.kg(‐1) melatonin 60 min before the procedure (group II)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.75 mg.kg(‐1) midazolam 15 min before the procedure (group III)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3 ml of 0.09 NaCl 15 min (group IV)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3 ml of 0.09 NaCl 60 min (group IV)
Number of subjects: 60
Study: 16554449

Group type: EXPERIMENTAL
Intervention: Etanercept (10 mg, 25 mg, 50 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 62
Study: 14583186

Group type: COMPARATOR
Intervention: CCR5-del32 allele in type I diabetes patients
Number of subjects: 149

Group type: COMPARATOR
Intervention: CCR5-del32 allele in type II diabetes patients
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Wild-type CCR5 genotype in type I diabetes
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Wild-type CCR5 genotype in type II diabetes
Number of subjects: 149
Study: 10553829

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg rapacuronium
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg rapacuronium
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.9 mg/kg rapacuronium
Number of subjects: 75
Study: 8723577

Group type: EXPERIMENTAL
Intervention: Epoetin alfa 50 to 150 IU/kg SC plus i.v. iron twice weekly for 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: i.v. iron alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 0
Study: 1929509

Group type: EXPERIMENTAL
Intervention: Ibuprofen 0.625 mg/kg
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ibuprofen 1.25 mg/kg
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ibuprofen 2.5 mg/kg
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Ibuprofen 5 mg/kg
Number of subjects: 93
Study: 6135300

Group type: EXPERIMENTAL
Intervention: Naloxone (400 micrograms, 1 ml injection)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sodium Chloride (0.9%, 1 ml injection)
Number of subjects: 30
Study: 30672091

Group type: EXPERIMENTAL
Intervention: IVIG (IgPro10, Privigen)
Number of subjects: 235
Study: 29159694

Group type: EXPERIMENTAL
Intervention: SDPM-CIP tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: CIPRO XR® bilayer tablets
Number of subjects: 0
Study: 28207527

Group type: EXPERIMENTAL
Intervention: Zhibitai 480 mg + atorvastatin 10 mg (ZA10 group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Atorvastatin 40 mg (A40 group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg (A20 group)
Number of subjects: 150
Study: 26180243

Group type: EXPERIMENTAL
Intervention: 6 g α-GOSs/d
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 12 g α-GOSs/d
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 18 g α-GOSs/d
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control (glucose syrup)
Number of subjects: 88
Study: 23979955

Group type: EXPERIMENTAL
Intervention: Denosumab (6 years total exposure)
Number of subjects: 4550

Group type: COMPARATOR
Intervention: Denosumab (3 years crossover from placebo)
Number of subjects: 4550
Study: 21371498

Group type: EXPERIMENTAL
Intervention: Exercise (360 min/week of moderate-to-vigorous aerobic exercise)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control
Number of subjects: 202
Study: 18322873

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonsurgical treatment (endoluminal stenting)
Number of subjects: 21
Study: 17725149

Group type: EXPERIMENTAL
Intervention: Ginger (0.5 gram per capsule, 2 capsules taken one hour before surgery)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 12716661

Group type: EXPERIMENTAL
Intervention: Trans meal (10% energy from trans 18:1 acids)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Cis meal (10% energy from oleic acid)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Trans meal
Number of subjects: 19

Group type: COMPARATOR
Intervention: Cis meal
Number of subjects: 19
Study: 10739506

Group type: EXPERIMENTAL
Intervention: Intranasal 17beta-estradiol (300 microg/d)
Number of subjects: 659

Group type: COMPARATOR
Intervention: Oral micronized estradiol (2 mg/d)
Number of subjects: 659
Study: 9189968

Group type: EXPERIMENTAL
Intervention: Oxybuprocaine 0.4% eyedrops
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diclofenac 0.1% eyedrops
Number of subjects: 40
Study: 8409683

Group type: EXPERIMENTAL
Intervention: razoxane
Number of subjects: 603
Study: 2985351

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30102886

Group type: EXPERIMENTAL
Intervention: Connective tissue massage (20-minute session)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Individualized attention (20 minutes)
Number of subjects: 165
Study: 27229315

Group type: EXPERIMENTAL
Intervention: KMC with a woolen cap
Number of subjects: 0

Group type: COMPARATOR
Intervention: KMC without a woolen cap
Number of subjects: 0
Study: 26051802

Group type: EXPERIMENTAL
Intervention: 44 Gy plus 90 Gy (103)Pd
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20 Gy with 115 Gy (103)Pd
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 Gy (20/0 trial)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0 Gy (20/0 trial)
Number of subjects: 0
Study: 23181832

Group type: EXPERIMENTAL
Intervention: 4 mg folic acid
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: 0.4 mg folic acid
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 6000
Study: 20970382

Group type: EXPERIMENTAL
Intervention: AAV2-neurturin (5·4 × 10¹¹ vector genomes) injected bilaterally into the putamen
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 58
Study: 19192860

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM) program with gift certificates for compliance delivered at 4- to 6-week intervals, total value = $390.00, with escalating gift certificates by $5.00 increments.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM) program with higher magnitude gift certificates and gradually decreased density of reinforcement.
Number of subjects: 0
Study: 15794392

Group type: EXPERIMENTAL
Intervention: Self-Injection Anxiety Therapy (SIAT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control telephone support condition
Number of subjects: 30
Study: 12213353

Group type: EXPERIMENTAL
Intervention: Lispro insulin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Regular insulin
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 33
Study: 10036345

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) 1 mg (4 puffs) plus 2.5 mg nebulized salbutamol
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo plus 2.5 mg nebulized salbutamol
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 7793584

Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intramuscular pethidine
Number of subjects: 60
Study: 1778084

Group type: EXPERIMENTAL
Intervention: Ser-316 suppository (3 suppositories/week for 6 months)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 371339

Group type: EXPERIMENTAL
Intervention: Levomepromazine, 12.5 mg
Number of subjects: 316

Group type: COMPARATOR
Intervention: Pethidine, 50 mg
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Levomepromazine
Number of subjects: 316

Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Levomepromazine and Pethidine
Number of subjects: 316
Study: 31679359

Group type: EXPERIMENTAL
Intervention: Fish + Walnut diet (150 g fish and 9 walnuts/week)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Fish diet (300 g/week)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Walnut diet (18 walnuts/week)
Number of subjects: 99
Study: 27913695

Group type: EXPERIMENTAL
Intervention: CoQ 2,400 mg/d
Number of subjects: 609

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 609
Study: 26291797

Group type: EXPERIMENTAL
Intervention: CC plus NAC
Number of subjects: 120

Group type: COMPARATOR
Intervention: CC only
Number of subjects: 120

Group type: COMPARATOR
Intervention: CC plus metformin
Number of subjects: 120